Trials / Completed
CompletedNCT02745678
Localized Therapeutics for the Treatment of Gastrointestinal Disorders II
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 8 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate a novel thermosensitive topical gel formulation for the treatment of inflammatory bowel disease (IBD), specifically ulcerative colitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Thermosensitive gel rectal formulation |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
- First posted
- 2016-04-20
- Last updated
- 2018-08-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02745678. Inclusion in this directory is not an endorsement.